• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Research Articles Abstract - 2013 Issues Archive

Research Articles Abstracts ? May 25 2013 Issue

Research Articles Abstracts ? May 25 2013 Issue

[Source: AMEDEO, homepage: http://www.amedeo.com ]

Research Articles Abstracts ? May 25 2013 Issue



This week?s abstracts:
  • Ann Intern Med
    • PAVIA AT
  • Antiviral Res
    • ARMSTRONG SM , Mubareka S, Lee WL
      • The lung microvascular endothelium as a therapeutic target in severe influenza.
    • ZHANG X , Qi X, Zhang Q, Zeng X, et al
      • Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades.
  • Arch Virol
    • CHO HG , Choi JH, Lee HK, Mun SK, et al
  • BMJ
  • J Immunol
    • FLORIDO M , Grima MA, Gillis CM, Xia Y, et al
      • Influenza A Virus Infection Impairs Mycobacteria-Specific T Cell Responses and Mycobacterial Clearance in the Lung during Pulmonary Coinfection.
  • J Infect Dis
    • MACKAY IM , Lambert SB, Faux CE, Arden KE, et al
      • Community-wide, contemporaneous circulation of a broad spectrum of human rhinoviruses in healthy Australian preschool-aged children during a 12-month period.
    • WALSH EE , Peterson DR, Kalkanoglu AE, Lee FE, et al
      • Viral shedding and immune responses to respiratory syncytial virus infection in older adults.
    • BONI MF , Chau NV, Dong N, Todd S, et al
  • J Virol
    • HEATON NS , Leyva-Grado VH, Tan GS, Eggink D, et al
      • In vivo bioluminescent imaging of influenza A virus infection and characterization of novel cross-protective monoclonal antibodies.
    • GOFF PH , Krammer F, Hai R, Seibert CW, et al
      • Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin.
    • SEIBERT CW , Rahmat S, Krause JC, Eggink D, et al
    • TSURUDOME M , Nakahashi M, Matsushima Y, Ito M, et al
      • Full conversion of the hemagglutinin-neuraminidase specificity of the parainfluenza virus 5 fusion protein by replacement of 21 amino acids in its head region with those of the simian virus 41 fusion protein.
  • JAMA
    • OSTERHOLM MT , Ballering KS, Kelley NS
      • Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9).
  • MMWR Morb Mortal Wkly Rep
    • ?
      • Value of Pharmacy-Based Influenza Surveillance - Ontario, Canada, 2009.
  • N Engl J Med
    • BLANKEN MO , Rovers MM, Molenaar JM, Winkler-Seinstra PL, et al
    • LEMANSKE RF JR
    • GAO HN , Lu HZ, Cao B, Du B, et al
    • BAO CJ , Cui LB, Zhou MH, Hong L, et al
  • PLoS Comput Biol
    • TRUSCOTT J , Ferguson NM
      • Evaluating the adequacy of gravity models as a description of human mobility for epidemic modelling.
    • RILEY P , Ben-Nun M, Armenta R, Linker JA, et al
      • Multiple Estimates of Transmissibility for the 2009 Influenza Pandemic Based on Influenza-like-Illness Data from Small US Military Populations.
  • PLoS One
    • CHADHA MS , Hirve S, Dawood FS, Lele P, et al
      • Burden of Seasonal and Pandemic Influenza-Associated Hospitalization during and after 2009 A(H1N1)pdm09 Pandemic in a Rural Community in India.
    • GOLDSTEIN T , Mena I, Anthony SJ, Medina R, et al
      • Pandemic H1N1 Influenza Isolated from Free-Ranging Northern Elephant Seals in 2010 off the Central California Coast.
    • PETRIE SM , Guarnaccia T, Laurie KL, Hurt AC, et al
      • Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.
    • VANDENDIJCK Y , Faes C, Hens N
      • Eight years of the great influenza survey to monitor influenza-like illness in flanders.
    • HEO JY , Chang SH, Go MJ, Kim YM, et al
      • Risk Perception, Preventive Behaviors, and Vaccination Coverage in the Korean Population during the 2009-2010 Pandemic Influenza A (H1N1): Comparison between High-Risk Group and Non-High-Risk Group.
    • TAKAHASHI T , Song J, Suzuki T, Kawaoka Y, et al
      • Mutations in NA That Induced Low pH-Stability and Enhanced the Replication of Pandemic (H1N1) 2009 Influenza A Virus at an Early Stage of the Pandemic.
    • GARCIA CC , Weston-Davies W, Russo RC, Tavares LP, et al
      • Complement C5 Activation during Influenza A Infection in Mice Contributes to Neutrophil Recruitment and Lung Injury.
  • Proc Natl Acad Sci U S A
    • YANG C , Skiena S, Futcher B, Mueller S, et al
      • Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice.
  • Vaccine
    • SHEN S , Campitelli MA, Calzavara A, Guttmann A, et al
      • Seasonal influenza vaccine effectiveness in pre- and full-term children aged 6-23 months over multiple seasons.
    • PABST LJ , Chaves SS, Weinbaum C
      • Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years.
    • NDEFFO MBAH ML , Medlock J, Meyers LA, Galvani AP, et al
      • Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty.
    • ?
      • Strengthening the influenza vaccine virus selection and development process: Outcome document of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conferences (CICG) Geneva, Switzerla
  • Virology
    • WANITCHANG A , Narkpuk J, Jongkaewwattana A
      • Nuclear import of influenza B virus nucleoprotein: Involvement of an N-terminal nuclear localization signal and a cleavage-protection motif.
  • Virus Res
    • CHAN RW , Chan MC, Nicholls JM, Peiris JS, et al
      • Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses.
-
-------
 
Research Articles Abstracts ? June 2 2013 Issue

Research Articles Abstracts ? June 2 2013 Issue

[Source: AMEDEO, homepage: http://www.amedeo.com ]

Research Articles Abstracts ? June 2 2013 Issue



This week?s abstracts:
________
  • Antiviral Res
    • SAMSON M , Pizzorno A, Abed Y, Boivin G, et al
      • Influenza Virus Resistance to Neuraminidase Inhibitors.
    • LEE YN , Youn HN, Kwon JH, Lee DH, et al
      • Sublingual administration of Lactobacillus rhamnosus affects respiratory immune responses and facilitates protection against influenza virus infection in mice.
    • HAASBACH E , Hartmayer C, Planz O
      • Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro.
  • Epidemiol Infect
    • BIGGERSTAFF M , Jhung MA, Reed C, Garg S, et al
      • Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010.
  • J Immunol
    • GRAHAM AC , Hilmer KM, Zickovich JM, Obar JJ, et al
      • Inflammatory Response of Mast Cells during Influenza A Virus Infection Is Mediated by Active Infection and RIG-I Signaling.
  • J Virol
    • WANG S , Zhao Z, Bi Y, Sun L, et al
      • Tyrosine 132 phosphorylation of influenza A virus M1 protein is crucial for virus replication by controlling its nuclear import.
    • MARTINEZ-ROMERO C , de Vries E, Belicha-Villanueva A, Mena I, et al
      • Substitutions T200A and E227A in the hemagglutinin of pandemic 2009 influenza A virus increase lethality but decrease transmission.
  • J Virol Methods
    • WANG R , Zhao J, Jiang T, Kwon YM, et al
      • Selection and characterization of DNA aptamers for use in detection of avian influenza virus H5N1.
  • PLoS One
    • FENICHEL EP , Kuminoff NV, Chowell G
    • ZOU J , Yang H, Cui H, Shu Y, et al
      • Geographic Divisions and Modeling of Virological Data on Seasonal Influenza in the Chinese Mainland during the 2006-2009 Monitoring Years.
    • LIU X , Liu Y, Zhang Y, Chen Z, et al
      • Pre-Existing Immunity with High Neutralizing Activity to 2009 Pandemic H1N1 Influenza Virus in Shanghai Population.
    • IBANEZ LI , Roose K, De Filette M, Schotsaert M, et al
      • M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A.
    • BOONYARATANAKORNKIT J , Schomacker H, Collins P, Schmidt A, et al
      • Alix Serves as an Adaptor That Allows Human Parainfluenza Virus Type 1 to Interact with the Host Cell ESCRT System.
    • SCHRAUWEN EJ , Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, et al
      • Reassortment between Avian H5N1 and Human Influenza Viruses Is Mainly Restricted to the Matrix and Neuraminidase Gene Segments.
    • MATHEU MP , Teijaro JR, Walsh KB, Greenberg ML, et al
      • Three Phases of CD8 T Cell Response in the Lung Following H1N1 Influenza Infection and Sphingosine 1 Phosphate Agonist Therapy.
    • VITELLI A , Quirion MR, Lo CY, Misplon JA, et al
      • Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo
    • WEAVER JM , Yang H, Roumanes D, Lee FE, et al
      • Increase in IFNgamma(-)IL-2(+) Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza.
  • Virus Res
    • SPACKMAN E , Swayne DE
      • Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: Current questions and new technology.
-
------
 
Research Articles Abstracts ? June 8 2013 Issue

Research Articles Abstracts ? June 8 2013 Issue

[Source: AMEDEO, homepage: http://www.amedeo.com ]

Research Articles Abstracts ? June 8 2013 Issue



This week?s abstracts:
  • Ann Intern Med
    • KE Y , Wang Y, Zhang W, Huang L, et al
      • Deaths Associated with Avian Influenza A(H7N9) Virus in China.
  • Arch Virol
    • HUANG Y , Zhu W, Zeng X, Li S, et al
  • Epidemiol Infect
    • INGLIS NJ , Bagnall H, Janmohamed K, Suleman S, et al
      • Measuring the effect of influenza A(H1N1)pdm09: the epidemiological experience in the West Midlands, England during the 'containment' phase.
  • J Immunol
    • SLUTTER B , Pewe LL, Lauer P, Harty JT, et al
      • Cutting Edge: Rapid Boosting of Cross-Reactive Memory CD8 T Cells Broadens the Protective Capacity of the Flumist Vaccine.
  • J Virol
    • SUN X , Jayaraman A, Maniprasad P, Raman R, et al
      • N-linked Glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.
  • J Virol Methods
    • AUDREY S , Marie-Odile LB, Carole G, Isabelle P, et al
      • Evaluation of a commercial ELISA for H5 low pathogenic avian influenza virus antibody detection in duck sera using Bayesian methods.
  • Lancet
    • HU Y , Lu S, Song Z, Wang W, et al
      • Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
  • N Engl J Med
    • MORENS DM , Taubenberger JK, Fauci AS
  • PLoS One
    • LEE HK , Tang JW, Kong DH, Koay ES, et al
    • PRICE JV , Jarrell JA, Furman D, Kattah NH, et al
      • Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.
  • Vaccine
    • PUIG-BARBERA J , Natividad-Sancho A, Calabuig-Perez J, Lluch-Rodrigo JA, et al
      • MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system.
  • Virology
    • WILLE M , Tolf C, Avril A, Latorre-Margalef N, et al
      • Frequency and patterns of reassortment in natural influenza A virus infection in a reservoir host.
  • Virus Res
    • SONNBERG S , Webby RJ, Webster RG
      • 2.1 Natural History of Highly Pathogenic Avian Influenza H5N1.
    • RIMMELZWAAN GF , Katz JM
    • GUAN Y , Smith GJ
      • The emergence and diversification of panzootic H5N1 influenza viruses.
-
------
 
Research Articles Abstracts?June 14 2013 Issue

Research Articles Abstracts?June 14 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?June 14 2013 Issue




This week?s abstracts:
_________
  • Antiviral Res
    • PALU G , Loregian A
      • Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
  • Biochem Biophys Res Commun
    • HIDARI KI , Yamaguchi M, Ueno F, Abe T, et al
      • Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells.
  • Cell
    • THARAKARAMAN K , Jayaraman A, Raman R, Viswanathan K, et al
      • Glycan Receptor Binding of the Influenza A Virus H7N9 Hemagglutinin.
  • J Infect
    • VIASUS D , Marinescu C, Villoslada A, Cordero E, et al
      • Community-acquired pneumonia during the first post-pandemic influenza season: A prospective, multicentre cohort (postp10-11) study from Spain.
  • J Infect Dis
    • AEFFNER F , Abdulrahman B, Hickman-Davis JM, Janssen P, et al
      • Heterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severity.
    • MUNSELL MF , Shah DP, Chemaly RF
    • FATKENHEUER G , Gillor D, Platten M, Kochanek M, et al
  • J Virol
    • KAPCZYNSKI DR , Pantin-Jackwood M, Guzman SG, Ricardez Y, et al
      • Characterization of the 2012 Highly Pathogenic Avian Influenza H7N3 virus isolated from poultry in an outbreak in Mexico: Pathobiology and Vaccine Protection.
    • LU X , Qi J, Shi Y, Wang M, et al
      • Structure and receptor binding specificity of the hemagglutinin H13 from avian influenza A virus H13N6.
  • MMWR Morb Mortal Wkly Rep
    • ?
      • Influenza activity - United States, 2012-13 season and composition of the 2013-14 influenza vaccine.
  • PLoS One
    • NGAI KL , Chan MC, Chan PK
      • Replication and Transcription Activities of Ribonucleoprotein Complexes Reconstituted from Avian H5N1, H1N1pdm09 and H3N2 Influenza A Viruses.
    • WAITHMAN J , Zanker D, Xiao K, Oveissi S, et al
      • Resident CD8(+) and Migratory CD103(+) Dendritic Cells Control CD8 T Cell Immunity during Acute Influenza Infection.
    • MUSCATELLO DJ , Newall AT, Dwyer DE, Macintyre CR, et al
      • Mortality attributable to seasonal and pandemic influenza, australia, 2003 to 2009, using a novel time series smoothing approach.
    • HYDER A , Buckeridge DL, Leung B
    • TURBELIN C , Souty C, Pelat C, Hanslik T, et al
      • Age Distribution of Influenza Like Illness Cases during Post-Pandemic A(H3N2): Comparison with the Twelve Previous Seasons, in France.
    • LIN SY , Wu ET, Lin CH, Shyu MK, et al
      • The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in taiwan.
    • RAJESH KUMAR S , Syed Khader SM, Kiener TK, Szyporta M, et al
      • Intranasal Immunization of Baculovirus Displayed Hemagglutinin Confers Complete Protection against Mouse Adapted Highly Pathogenic H7N7 Reassortant Influenza Virus.
    • HALBHERR SJ , Brostoff T, Tippenhauer M, Locher S, et al
      • Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus.
    • YUAN Q , Nsoesie EO, Lv B, Peng G, et al
  • Proc Natl Acad Sci U S A
    • TREGONING JS , Wang BL, McDonald JU, Yamaguchi Y, et al
      • Neonatal antibody responses are attenuated by interferon-gamma produced by NK and T cells during RSV infection.
  • Vaccine
    • JANG YH , Jung EJ, Byun YH, Lee KH, et al
      • Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.
    • SEGURA-VELAZQUEZ R , Cervantes J, Acosta E, Sanchez-Betancourt I, et al
      • Influenza vaccine: Development of a novel intranasal and subcutaneous recombinant adjuvant.
-
-------
 
Research Articles Abstracts?June 23 2013 Issue

Research Articles Abstracts?June 23 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?June 23 2013 Issue



This week?s abstracts:
________
  • Arch Virol
    • MARUYAMA J , Okamatsu M, Soda K, Sakoda Y, et al
      • Factors responsible for pathogenicity in chickens of a low-pathogenic H7N7 avian influenza virus isolated from a feral duck.
    • SARKADI J , Jankovics M, Kis Z, Skare J, et al
      • Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.
    • BALMAKS R , Ribakova I, Gardovska D, Kazaks A, et al
      • Molecular epidemiology of respiratory syncytial virus during the 2009-2010 season in Latvia.
  • BMJ
  • J Clin Microbiol
    • CHAN KH , To KK, Chan JF, Li CP, et al
      • Evaluation of analytical sensitivity of seven point-of-care influenza detection kits and two molecular tests for detection of avian-origin H7N9 and swine-origin H3N2 variant influenza A viruses.
  • J Immunol
    • BONDUELLE O , Yahia N, Siberil S, Benhabiles N, et al
      • Longitudinal and Integrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination.
  • J Virol
    • WAN H , Gao J, Xu K, Chen H, et al
      • Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as well as H5N1 Influenza Viruses.
  • J Virol Methods
    • MURILLO L , Hardick J, Jeng K, Gaydos CA, et al
      • Evaluation of the Pan Influenza detection kit utilizing the PLEX-ID and influenza samples from the 2011 respiratory season.
  • Lancet
    • ZHU Y , Qi X, Cui L, Zhou M, et al
      • Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China.
  • N Engl J Med
  • PLoS One
    • HUANG L , Li L, Klonowski KD, Tompkins SM, et al
      • Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection.
    • SHOJI M , Takahashi E, Hatakeyama D, Iwai Y, et al
    • CHOI HJ , Ebersbacher CF, Kim MC, Kang SM, et al
      • A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment.
    • MCKIMM-BRESCHKIN JL , Barrett S, Pudjiatmoko, Azhar M, et al
      • I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses.
    • RAMANUNNINAIR M , Le J, Onodera S, Fulvini AA, et al
      • Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.
  • Vaccine
    • DODD CN , Romio SA, Black S, Vellozzi C, et al
      • International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    • LAUNAY O , Paul S, Servettaz A, Roguet G, et al
      • Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.
-
-------
 
Research Articles Abstracts?June 29 2013 Issue

Research Articles Abstracts?June 29 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?June 29 2013 Issue




This week?s abstracts:
________
  • Antiviral Res
    • TORRES E , Duque MD, Vanderlinden E, Ma C, et al
      • Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds.
    • ENGEL DA
      • The influenza virus NS1 protein as a therapeutic target.
    • DAPAT C , Kondo H, Dapat IC, Baranovich T, et al
      • Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
  • Arch Virol
    • LEE YN , Lee C
  • BMJ
    • DAI C , Jiang M
    • IP DK , Liao Q, Wu P, Gao Z, et al
      • Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series.
  • Epidemiol Infect
    • NA W , Kang B, Kim HI, Hong M, et al
      • Isolation and genetic characterization of naturally NS-truncated H3N8 equine influenza virus in South Korea.
  • J Immunol
    • GHONEIM HE , Thomas PG, McCullers JA
      • Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections.
    • NAYAK JL , Alam S, Sant AJ
      • Cutting Edge: Heterosubtypic Influenza Infection Antagonizes Elicitation of Immunological Reactivity to Hemagglutinin.
  • J Virol
    • MAHALLAWI WH , Kasbekar AV, McCormick MS, Hoschler K, et al
      • Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.
    • MASON JN , Elbahesh H, Russell CJ
      • Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based HPIV3 vaccines.
    • LI Z , Gabbard JD, Mooney A, Chen Z, et al
    • HACH JC , McMichael T, Chesarino NM, Yount JS, et al
      • Palmitoylation on conserved and non-conserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity.
    • DENG G , Tan D, Shi J, Cui P, et al
      • Complex reassortment of multiple subtypes of avian influenza viruses in domestic ducks at the Dongting Lake region of China.
  • Lancet
    • COWLING BJ , Jin L, Lau EH, Liao Q, et al
      • Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases.
    • YU H , Cowling BJ, Feng L, Lau EH, et al
      • Human infection with avian influenza A H7N9 virus: an assessment of clinical severity.
    • VIBOUD C , Simonsen L
  • PLoS One
    • GULATI S , Smith DF, Cummings RD, Couch RB, et al
      • Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread.
    • BAKRE A , Andersen LE, Meliopoulos V, Coleman K, et al
      • Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.
    • GREER AL , Schanzer D
      • Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty.
    • ALLERSON MW , Cardona CJ, Torremorell M
      • Indirect Transmission of Influenza A Virus between Pig Populations under Two Different Biosecurity Settings.
    • ZHOU B , Pearce MB, Li Y, Wang J, et al
      • Asparagine Substitution at PB2 Residue 701 Enhances the Replication, Pathogenicity, and Transmission of the 2009 Pandemic H1N1 Influenza A Virus.
  • Vaccine
    • PULCINI C , Massin S, Launay O, Verger P, et al
      • Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: A 2010 survey.
    • CONNIE LEUNG YH , Luk G, Sia SF, Wu YO, et al
      • Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
-
--------
 
Research Articles Abstracts?July 7 2013 Issue

Research Articles Abstracts?July 7 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?July 7 2013 Issue




This week?s Abstracts:
________
  • Antiviral Res
    • CHEN HW , Cheng JX, Liu MT, King K, et al
      • Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses.
    • KIM MC , Lee JS, Kwon YM, Eunju O, et al
      • Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and tronger M2 immunity than live influenza A virus infection.
    • HAASBACH E , Reiling SJ, Ehrhardt C, Droebner K, et al
      • The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
  • BMJ
  • Cell
    • GARCIA-SASTRE A
    • BRANDES M , Klauschen F, Kuchen S, Germain RN, et al
      • A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection.
    • TAM VC , Quehenberger O, Oshansky CM, Suen R, et al
      • Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation.
  • Eur J Epidemiol
    • TENNANT PW , Parker L, Thomas JE, Craft SA, et al
      • Childhood infectious disease and premature death from cancer: a prospective cohort study.
  • J Clin Microbiol
    • VAN WESENBEECK L , Meeuws H, Van Immerseel A, Ispas G, et al
      • Comparison of the Filmarray RP, the Verigene RV+ and the Prodesse ProFLU+/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium.
  • J Infect Dis
    • JEGASKANDA S , Laurie KL, Amarasena TH, Winnall WR, et al
  • J Virol
    • LI Q , Qi J, Wu Y, Kiyota H, et al
      • Functional and structural analysis of influenza neuraminidase N3 offers further insight into the mechanisms of oseltamivir-resistance.
    • MAGADAN JG , Khurana S, Das SR, Frank GM, et al
    • LOVING CL , Lager KM, Vincent AL, Brockmeier SL, et al
      • Efficacy of inactivated and live-attenuated influenza virus vaccines in pigs against infection and transmission of emerging H3N2 similar to the 2011-2012 H3N2v.
    • LI Y , Bostick DL, Sullivan CB, Myers JL, et al
      • Single Hemagglutinin Mutations that Alter Both Antigenicity and Receptor Binding Avidity Influence Influenza Virus Antigenic Clustering.
    • ZARAKET H , Bridges OA, Duan S, Baranovich T, et al
      • Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets.
    • HARDER TC , Grosse Beilage E, Lange E, Meiners C, et al
      • Expanded co-circulation of stable subtypes, emerging lineages and new sporadic reassortants of porcine influenza viruses in swine populations in Northwest Germany.
    • STEVAERT A , Dallocchio R, Dessi A, Pala N, et al
      • Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease.
  • JAMA
  • N Engl J Med
    • SALATHE M , Freifeld CC, Mekaru SR, Tomasulo AF, et al
  • PLoS One
    • HASHEM AM , Flaman AS, Farnsworth A, Brown EG, et al
      • Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases.
    • MENG W , Pan W, Zhang AJ, Li Z, et al
      • Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases.
  • Vaccine
    • KREIJTZ JH , Kroeze EV, Stittelaar KJ, de Waal L, et al
      • Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: A model to study intervention strategies.
    • GIRARD MP , Tam JS, Pervikov Y, Katz JM, et al
        • Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.
-
-------
 
Research Articles Abstracts?July 13 2013 Issue

Research Articles Abstracts?July 13 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?July 13 2013 Issue




This week?s abstracts:
________
  • Antimicrob Agents Chemother
    • DAI JP , Wu LQ, Li R, Zhao XF, et al
      • Identification of 23-(S)-2-Amino-3-Phenylpropanoyl-Silybin as an Antiviral Agent for Influenza A Virus Infection in Vitro and in Vivo.
  • Antiviral Res
    • FEDSON DS
      • Treating Influenza with Statins and Other Immunomodulatory Agents.
  • Arch Virol
    • HE L , Zhao G, Zhong L, Liu Q, et al
      • Isolation and characterization of two H5N1 influenza viruses from swine in Jiangsu Province of China.
  • BMJ
  • Epidemiol Infect
    • KLICK B , Nishiura H, Leung GM, Cowling BJ, et al
      • Optimal design of studies of influenza transmission in households. II: Comparison between cohort and case-ascertained studies.
  • J Exp Med
    • BALLESTEROS-TATO A , Leon B, Lund FE, Randall TD, et al
      • CD4+ T helper cells use CD154-CD40 interactions to counteract T reg cell-mediated suppression of CD8+ T cell responses to influenza.
  • J Infect
    • GAAJETAAN GR , Geelen TH, Vernooy JH, Dentener MA, et al
      • Interferon-beta induces a long-lasting antiviral state in human respiratory epithelial cells.
  • J Infect Dis
    • DOLIN R
    • LANGLEY JM , Carmona Martinez A, Chatterjee A, Halperin SA, et al
      • Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children.
  • J Virol
    • WATANABE T , Tisoncik-Go J, Tchitchek N, Watanabe S, et al
      • 1918 Influenza virus hemagglutinin (HA) and the viral RNA polymerase complex enhance viral pathogenicity, but only HA induces aberrant host responses in mice.
    • MASIC A , Pyo HM, Babiuk S, Zhou Y, et al
      • An eight-segment swine influenza virus harbouring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.
    • ROBERTS KL , Leser GP, Ma C, Lamb RA, et al
      • The amphipathic helix of influenza A virus M2 protein is required for filamentous bud formation and scission of filamentous and spherical particles.
    • LONG JS , Howard WA, Nunez A, Moncorge O, et al
      • The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage.
  • N Engl J Med
  • PLoS One
    • GEFENAITE G , Tacken M, Bos J, Stirbu-Wagner I, et al
      • Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination.
    • KOSTOVA D , Reed C, Finelli L, Cheng PY, et al
      • Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011.
    • STOCKMAN LJ , Brooks WA, Streatfield PK, Rahman M, et al
      • Challenges to evaluating respiratory syncytial virus mortality in Bangladesh, 2004-2008.
    • MOWLS DS , Cheruvu VK, Zullo MD
      • Influenza vaccination in adults with chronic obstructive pulmonary disease: the impact of a diagnostic breathing test on vaccination rates.
    • KITAGAWA H , Kawano M, Yamanaka K, Kakeda M, et al
      • Intranasally Administered Antigen 85B Gene Vaccine in Non-Replicating Human Parainfluenza Type 2 Virus Vector Ameliorates Mouse Atopic Dermatitis.
    • TELLEZ-SOSA J , Rodriguez MH, Gomez-Barreto RE, Valdovinos-Torres H, et al
      • Using High-Throughput Sequencing to Leverage Surveillance of Genetic Diversity and Oseltamivir Resistance: A Pilot Study during the 2009 Influenza A(H1N1) Pandemic.
    • CHABAN B , Albert A, Links MG, Gardy J, et al
      • Characterization of the Upper Respiratory Tract Microbiomes of Patients with Pandemic H1N1 Influenza.
    • GREENE SK , Rett MD, Vellozzi C, Li L, et al
      • Guillain-Barre Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
    • TRAN DN , Pham TM, Ha MT, Tran TT, et al
      • Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam.
  • Vaccine
    • JORGENSEN P , Wasley A, Mereckiene J, Cotter S, et al
      • Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009.
    • SESTER U , Schmidt T, Kuhlmann MK, Gartner BC, et al
      • Serial influenza-vaccination reveals impaired maintenance of specific T-cell memory in patients with end-stage renal failure.
    • ANGGRAENI MR , Connors NK, Wu Y, Chuan YP, et al
      • Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle.
    • CHIT A , Parker J, Halperin SA, Papadimitropoulos M, et al
      • Toward more specific and transparent research and development costs: The case of seasonal influenza vaccines.
    • THOMPSON MG , McIntyre AF, Naleway AL, Black C, et al
      • Potential influence of seasonal influenza vaccination requirement versus traditional vaccine promotion strategies on unvaccinated healthcare personnel.
    • NIQUEUX E , Guionie O, Amelot M, Jestin V, et al
      • Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    • NEWCOMER SR , Hambidge SJ, McClure DL, Daley MF, et al
      • Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children.
    • DALY JM , Elton D
      • Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy.
    • KHODYAKOV D , Uscher-Pines L, Lorick S, Lindley MC, et al
      • A qualitative analysis of the impact of healthcare personnel influenza vaccination requirements in California.
-
------
 
Research Articles Abstracts?July 22 2013 Issue

Research Articles Abstracts?July 22 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?July 22 2013 Issue




This week?s abstracts:
________
  • Ann Intern Med
    • KE Y , Wang Y, Zhang W, Huang L, et al
  • J Clin Microbiol
    • WU LT , Thomas I, Curran MD, Ellis JS, et al
  • J Exp Med
    • LI Y , Myers JL, Bostick DL, Sullivan CB, et al
  • J Infect Dis
    • CHAVES SS , Aragon D, Bennett N, Cooper T, et al
      • Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.
    • MINA MJ , Klugman KP, McCullers JA
      • LAIV, but not PCV, protects against increased density and duration of pneumococcal carriage following influenza infection in pneumococcal colonized mice.
  • J Virol
    • MIN JY , Santos C, Fitch A, Twaddle A, et al
    • BLUMENKRANTZ D , Roberts KL, Shelton H, Lycett S, et al
      • The short stalk length of HPAI H5N1 influenza neuraminidase limits transmission of pandemic H1N1 virus in ferrets.
    • TE VELTHUIS AJ , Turrell L, Vreede FT, Fodor E, et al
      • Uncoupling of influenza A virus transcription and replication through mutation of the unpaired adenosine in the vRNA promoter.
    • VIJAYKRISHNA D , Deng YM, Su YC, Fourment M, et al
      • The recent establishment of North American H10 lineage influenza viruses in Australian wild waterfowl and the evolution of Australian avian influenza viruses.
    • PASCUA PN , Song MS, Kwon HI, Lim GJ, et al
      • The homologous tripartite viral RNA polymerase of A/swine/Korea/CT1204/2009(H1N2) influenza virus synergistically drives efficient replication and promotes respiratory-droplet transmission in ferrets.
  • J Virol Methods
    • RUTVISUTTINUNT W , Chinnawirotpisan P, Simasathien S, Shrestha SK, et al
      • Simultaneous and Complete Genome Sequencing of Influenza A and B with High Coverage by Illumina MiSeq Platform.
    • KIS Z , Jones J, Creanga A, Ferdinand K, et al
      • Real-time RT-PCR Assay to Differentiate Clades of H5N1 Avian Influenza Viruses Circulating in Vietnam.
  • Lancet
  • N Engl J Med
    • MEMISH ZA , Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, et al
  • Pediatrics
    • YIN J , Schweizer ML, Herwaldt LA, Pottinger JM, et al
      • Benefits of universal gloving on hospital-acquired infections in acute care pediatric units.
  • Vaccine
    • NJUGUNA H , Ahmed J, Oria PA, Arunga G, et al
      • Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    • YANG WH , Dionne M, Kyle M, Aggarwal N, et al
      • Long-term immunogenicity of an AS03-adjuvanted influenza A (H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial.
    • SULLIVAN SG , Tay EL, Kelly H
      • Variable definitions of the influenza season and their impact on vaccine effectiveness estimates.
  • Virology
    • CREANGA A , Thi Nguyen D, Gerloff N, Thi Do H, et al
      • Emergence of multiple clade 2.3.2.1 influenza A (H5N1) virus subgroups in Vietnam and detection of novel reassortants.
-
------
 
Research Articles Abstracts?July 28 2013 Issue

Research Articles Abstracts?July 28 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts?July 28 2013 Issue


This week?s abstracts:
________
  • Epidemiol Infect
    • NOH JY , Song JY, Hwang SY, Choi WS, et al
  • J Immunol
    • HEMANN EA , Kang SM, Legge KL
      • Protective CD8 T Cell-Mediated Immunity against Influenza A Virus Infection following Influenza Virus-Like Particle Vaccination.
    • GARNER-SPITZER E , Wagner A, Paulke-Korinek M, Kollaritsch H, et al
      • Tick-Borne Encephalitis and Hepatitis B Nonresponders Feature Different Immunologic Mechanisms in Response to Tick-Borne Encephalitis and Influenza Vaccination with Involvement of Regulatory T and B Cells and IL-10.
  • J Infect Dis
    • DU L , Li Y, Zhao G, Wang L, et al
      • Highly pathogenic avian influenza H5N1 mutants with air-transmissibility are susceptible to human and animal neutralizing antibodies.
  • J Virol
    • BUEHLER J , Navi D, Lorusso A, Vincent A, et al
      • Influenza A virus PB1-F2 protein expression is regulated in a strain-specific manner by sequences located downstream of the PB1-F2 initiation codon.
    • SULLI C , Banik SS, Schilling J, Moser A, et al
      • Detection of proton movement directly across viral membranes to identify novel influenza M2 inhibitors.
  • J Virol Methods
    • SHCHERBIK S , Sergent SB, Davis WG, Shu B, et al
      • Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.
  • PLoS One
    • CHENG AC , Holmes M, Irving LB, Brown SG, et al
      • Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010-11 Seasons: A Test-negative Observational Study.
    • FARRELL M , Sebeny P, Klena JD, Demattos C, et al
      • Influenza Risk Management: Lessons Learned from an A(H1N1) pdm09 Outbreak Investigation in an Operational Military Setting.
    • GERLOFF NA , Jones J, Simpson N, Balish A, et al
      • A High Diversity of Eurasian Lineage Low Pathogenicity Avian Influenza A Viruses Circulate among Wild Birds Sampled in Egypt.
    • BANERJEE I , Yamauchi Y, Helenius A, Horvath P, et al
      • High-Content Analysis of Sequential Events during the Early Phase of Influenza A Virus Infection.
    • KURIBAYASHI S , Sakoda Y, Kawasaki T, Tanaka T, et al
      • Excessive cytokine response to rapid proliferation of highly pathogenic avian influenza viruses leads to fatal systemic capillary leakage in chickens.
    • JIN Z , Smith LK, Rajwanshi VK, Kim B, et al
      • The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-Triphosphate towards Influenza A Virus Polymerase.
    • HUR KY , Moon JY, Kim SH, Yoo JY, et al
      • Model-Based Simulation and Prediction of an Antiviral Strategy against Influenza A Infection.
    • UEDA R , Sugiura T, Kume S, Ichikawa A, et al
      • A novel single virus infection system reveals that influenza virus preferentially infects cells in g1 phase.
    • WORTZMAN ME , Lin GH, Watts TH
      • Intrinsic TNF/TNFR2 Interactions Fine-Tune the CD8 T Cell Response to Respiratory Influenza Virus Infection in Mice.
    • GOPINATH SC , Awazu K, Fujimaki M, Shimizu K, et al
      • Observations of immuno-gold conjugates on influenza viruses using waveguide-mode sensors.
    • DER HEIDEN MA , Kopke K, Buda S, Buchholz U, et al
      • Estimates of excess medically attended acute respiratory infections in periods of seasonal and pandemic influenza in Germany from 2001/02 to 2010/11.
    • HAUSER MJ , Dlugolenski D, Culhane MR, Wentworth DE, et al
      • Antiviral responses by Swine primary bronchoepithelial cells are limited compared to human bronchoepithelial cells following influenza virus infection.
    • SHINAHARA W , Takahashi E, Sawabuchi T, Arai M, et al
      • Immunomodulator clarithromycin enhances mucosal and systemic immune responses and reduces re-infection rate in pediatric patients with influenza treated with antiviral neuraminidase inhibitors: a retrospective analysis.
    • SAMAAN G , McPherson M, Partridge J
      • A Review of the Evidence to Support Influenza Vaccine Introduction in Countries and Areas of WHO's Western Pacific Region.
    • SIMONSEN KA , Hunskaar S, Sandvik H, Rortveit G, et al
  • Proc Natl Acad Sci U S A
    • HERTZ T , Oshansky CM, Roddam PL, Devincenzo JP, et al
      • HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection.
  • Vaccine
    • LIAO Q , Wong WS, Fielding R
      • How anticipated worry and regret predict seasonal influenza vaccination uptake among Chinese adults?
    • SZURGOT I , Szolajska E, Laurin D, Lambrecht B, et al
      • Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.
  • Virology
    • KOHIO HP , Adamson AL
      • Glycolytic control of vacuolar-type ATPase activity: A mechanism to regulate influenza viral infection.
-
-------
 
Research Articles Abstracts?August 2 2013 Issue

Research Articles Abstracts?August 2 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts?August 2 2013 Issue


This week?s abstracts:
_________

  • Antiviral Res
    • MARTINEZ-GIL L , Alamares-Sapuay JG, Ramana Reddy MV, Goff PH, et al
      • A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
  • BMJ
  • J Clin Microbiol
    • WANG J , Tai W, Angione S, John AR, et al
      • Subtyping Clinical Specimens of Influenza A Virus using a Simple Method to Amplify RNA Targets (SMART).
  • J Gen Virol
    • KITIKOON P , Nelson MI, Killian ML, Anderson TK, et al
  • J Infect Dis
    • HUANG CH , Chen CJ, Yen CT, Yu CP, et al
      • Caspase-1 deficient mice are more susceptible to influenza A virus infection with PA variation.
    • HERBERG JA , Kaforou M, Gormley S, Sumner ER, et al
      • Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.
    • WEINBERGER DM , Harboe ZB, Viboud C, Krause TG, et al
  • J Virol
    • TURNER TM , Jones LP, Tompkins SM, Tripp RA, et al
    • MARGINE I , Krammer F, Hai R, Heaton NS, et al
      • Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect Against Group 2 Influenza A Viruses.
    • TIAN B , Zhao Y, Kalita M, Edeh CB, et al
      • CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.
    • DREYFUS C , Ekiert DC, Wilson IA
      • Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin.
  • J Virol Methods
    • MOSTAFA A , Kanrai P, Ziebuhr J, Pleschka S, et al
      • Improved dual promotor-driven reverse genetics system for influenza viruses.
    • LEON MB , Penuelas-Urquides K, Aguado-Barrera ME, Curras-Tuala MJ, et al
      • In vitro transcribed RNA molecules for the diagnosis of pandemic 2009 influenza A(H1N1) virus by real-time RT-PCR.
    • GRUND S , Pietzonka S, Michel S, Adams O, et al
      • Serum antibodies against native and denaturated hemagglutinin glycoproteins detected by ELISA as correlates of protection after influenza vaccination in healthy vaccinees and in kidney transplant recipients.
  • PLoS One
    • STEVENS NE , Fraser CK, Alsharifi M, Brown MP, et al
      • An Empirical Approach towards the Efficient and Optimal Production of Influenza-Neutralizing Ovine Polyclonal Antibodies Demonstrates That the Novel Adjuvant CoVaccine HT Is Functionally Superior to Freund's Adjuvant.
    • BERNIER A , Ligier C, Guillemot D, Watier L, et al
      • Did Media Attention of the 2009 A(H1N1) Influenza Epidemic Increase Outpatient Antibiotic Use in France?: A Time-Series Analysis.
    • KIM EK , Seok JH, Oh JS, Lee HW, et al
    • JIMENEZ-ALBERTO A , Alvarado-Facundo E, Ribas-Aparicio RM, Castelan-Vega JA, et al
      • Analysis of Adaptation Mutants in the Hemagglutinin of the Influenza A(H1N1)pdm09 Virus.
    • LIAO Q , Wong WS, Fielding R
      • Comparison of Different Risk Perception Measures in Predicting Seasonal Influenza Vaccination among Healthy Chinese Adults in Hong Kong: A Prospective Longitudinal Study.
  • Proc Natl Acad Sci U S A
    • ESPINOZA JA , Bohmwald K, Cespedes PF, Gomez RS, et al
      • Impaired learning resulting from respiratory syncytial virus infection.
  • Vaccine
    • SMITH GE , Flyer DC, Raghunandan R, Liu Y, et al
      • Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
  • Virology
    • KIM HM , Kang YM, Ku KB, Park EH, et al
      • The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus.
    • SHICHINOHE S , Okamatsu M, Sakoda Y, Kida H, et al
      • Selection of H3 avian influenza viruses with SAalpha2,6Gal receptor specificity in pigs.
  • Virus Res
    • VEMULA SV , Pandey A, Singh N, Katz JM, et al
      • Adenoviral vector expressing murine beta-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice.
    • KERVIEL A , Thomas A, Chaloin L, Favard C, et al
    • LAN YC , Su MC, Chen CH, Huang SH, et al
      • Epidemiology of pandemic influenza A/H1N1 virus during 2009-2010 in Taiwan.
-
-------
 
Research Articles Abstracts?August 10 2013 Issue

Research Articles Abstracts?August 10 2013 Issue

[Source: AMEDEO, homepage: (LINK).]
Research Articles Abstracts?August 10 2013 Issue


This week?s abstracts:
_________
  1. KROL E, Wandzik I, Gromadzka B, Nidzworski D, et al.
  2. QI X, Qian YH, Bao CJ, Guo XL, et al.
  3. LAU SK, Woo PC, Wu Y, Wong AY, et al.
  4. ZHOU Y, Kang MJ, Jha BK, Silverman RH, et al.
  5. CUNHA BA.
  6. WOLTER N, Cohen C, Tempia S, Madhi SA, et al.
  7. NG S, Fang VJ, Ip DK, Chan KH, et al.
  8. LOHRMANN F, Dijkman R, Stertz S, Thiel V, et al.
  9. GOTO H, Muramoto Y, Noda T, Kawaoka Y, et al.
  10. MYERS JL, Wetzel KS, Linderman SL, Li Y, et al.
  11. HU J, Hu Z, Mo Y, Wu Q, et al.
  12. BOUSSE T, Shore DA, Goldsmith CS, Hossain MJ, et al.
  13. PERLMAN S, McCray PB Jr.
  14. ASSIRI A, McGeer A, Perl TM, Price CS, et al.
  15. PANG IK, Pillai PS, Iwasaki A.
  16. NGUYEN YT, Graitcer SB, Nguyen TH, Tran DN, et al.
  17. SANGAWA H, Komeno T, Nishikawa H, Yoshida A, et al.
  18. MARJUKI H, Mishin VP, Sleeman K, Okomo-Adhiambo M, et al.
_________
We have screened the following journals for you:
  • Am J Med
  • Ann Intern Med
  • Antimicrob Agents Chemother
  • Antiviral Res
  • Arch Intern Med
  • Arch Virol
  • Biochem Biophys Res Commun
  • Biochem Soc Trans
  • Biochemistry
  • BMJ
  • Cell
  • Clin Diagn Lab Immunol
  • Commun Dis Rep CDR Wkly
  • Drug Saf
  • Drugs
  • Epidemiol Infect
  • Eur J Epidemiol
  • J Clin Microbiol
  • J Epidemiol Community Health?
  • J Exp Med
  • J Gen Virol
  • J Immunol
  • J Infect
  • J Infect Dis
  • J Virol
  • J Virol Methods
  • JAMA
  • Lancet?
  • MMWR Morb Mortal Wkly Rep
  • N Engl J Med
  • Pediatrics
  • Proc Natl Acad Sci U S A
  • Vaccine
  • Virology
  • Virus Res
-
------
 
Research Articles Abstracts?August 17 2013 Issue

Research Articles Abstracts?August 17 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts?August 17 2013 Issue

_______

This week?s abstracts:
________
  • Antiviral Res
    • BEYLEVELD G , White KM, Ayllon J, Shaw ML, et al
      • New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.
    • YODSHEEWAN R , Maneewatch S, Srimanote P, Thueng-In K, et al
      • Human monoclonal ScFv specific to NS1 protein inhibits replication of influenza viruses across types and subtypes.
  • Arch Virol
    • SHENG Z , Ran Z, Wang D, Hoppe AD, et al
  • Drugs
    • YANG LP
      • Recombinant Trivalent Influenza Vaccine (Flublok): A Review of Its Use in the Prevention of Seasonal Influenza in Adults.
  • J Gen Virol
    • HARA K , Nakazono Y, Kashiwagi T, Hamada N, et al
      • Co-incorporation of the PB2 and PA polymerase subunits from human H3N2 influenza virus is a critical determinant of the replication of reassortant ribonucleoprotein complexes.
  • J Infect
    • XU W , Sun Z, Liu Q, Xu J, et al
      • PA-356R is a unique signature of the avian influenza A (H7N9) viruses with bird-to-human transmissibility: potential implication for animal surveillances.
    • HSIEH SM , Huang YS, Chang SY, Lin PH, et al
      • Serological survey in close contacts with a confirmed case of H7N9 influenza in Taiwan.
  • J Infect Dis
    • REDFORD PS , Mayer-Barber KD, McNab FW, Stavropoulos E, et al
      • Influenza A virus impairs control of Mycobacterium tuberculosis co-infection through a Type I Interferon receptor dependent pathway.
  • J Virol
    • KRUIJSEN D , Einarsdottir HK, Schijf MA, Coenjaerts FE, et al
      • Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice.
  • J Virol Methods
    • LU G , Yan H, Yang Y, Cui S, et al
      • Evaluation of two commercial real-time PCR kits for detection of pandemic (H1N1) 2009 virus in Beijing.
  • N Engl J Med
  • PLoS One
    • TURNER C , Turner P, Carrara V, Burgoine K, et al
      • High rates of pneumonia in children under two years of age in a South East Asian refugee population.
    • KOK J , Blyth CC, Foo H, Bailey MJ, et al
      • Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus.
    • MITCHELL HD , Eisfeld AJ, Sims AC, McDermott JE, et al
      • A Network Integration Approach to Predict Conserved Regulators Related to Pathogenicity of Influenza and SARS-CoV Respiratory Viruses.
    • LIU H , Patil HP, de Vries-Idema J, Wilschut J, et al
      • Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies.
    • YUAN XT , Zhang T, Wan XF
      • A joint matrix completion and filtering model for influenza serological data integration.
    • GE Y , Wu B, Qi X, Zhao K, et al
      • Rapid and Sensitive Detection of Novel Avian-Origin Influenza A (H7N9) Virus by Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Lateral-Flow Device.
    • GAGNON A , Miller MS, Hallman SA, Bourbeau R, et al
      • Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality.
  • Proc Natl Acad Sci U S A
    • SPENSIERI F , Borgogni E, Zedda L, Bardelli M, et al
      • Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses.
  • Vaccine
    • VAN BUYNDER PG , Konrad S, Van Buynder JL, Brodkin E, et al
      • The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly.
    • KAVANAGH K , Robertson C, McMenamin J
      • Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method-Experience across the 2010/11 season.
-
-------
 
Research Articles Abstracts?August 24 2013 Issue

Research Articles Abstracts?August 24 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts?August 24 2013 Issue


This week?s abstracts:
________
  • Antiviral Res
    • HE F , Kumar SR, Khader SM, Tan Y, et al
      • Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus.
    • KIM M , Kim SY, Lee HW, Shin JS, et al
      • Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.
    • KAKUTA M , Kubo S, Tanaka M, Tobiume S, et al
      • Efficacy of a single intravenous administration of laninamivir (an active metabolite of laninamivir octanoate) in an influenza virus infection mouse model.
  • Arch Virol
    • CUI Z , Hu J, He L, Li Q, et al
      • Differential immune response of mallard duck peripheral blood mononuclear cells to two highly pathogenic avian influenza H5N1 viruses with distinct pathogenicity in mallard ducks.
  • Biochem Biophys Res Commun
    • WAUGH T , Ching JC, Zhou Y, Loewen ME, et al
      • Influenza A virus (H1N1) increases airway epithelial cell secretion by up-regulation of potassium channel KCNN4.
  • Epidemiol Infect
    • DE DONNO A , Idolo A, Quattrocchi M, Zizza A, et al
  • J Clin Microbiol
    • HATCHETTE TF , Drews SJ, Bastien N, Li Y, et al
  • J Gen Virol
    • NEUBAUER D , Aumayr M, Gosler I, Skern T, et al
      • Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues.
    • RAMOS I , Krammer F, Hai R, Aguilera D, et al
      • H7N9 influenza viruses interact preferentially with alpha2,3-linked sialic acids and bind weakly to alpha2,6-linked sialic acids.
    • LEE YN , Lee DH, Park JK, Yuk SS, et al
  • J Immunol
    • METZGER DW , Sun K
    • GRODELAND G , Mjaaland S, Roux KH, Fredriksen AB, et al
      • DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza.
  • J Infect
    • LIU S , Sun J, Cai J, Miao Z, et al
      • A comparison of the epidemiological, clinical and viral characteristics between survivors and deaths infected with human avian influenza a (H7N9) virus in Zhejiang province, China.
  • J Virol
    • ABE M , Tahara M, Sakai K, Yamaguchi H, et al
    • KOCER ZA , Obenauer J, Zaraket H, Zhang J, et al
  • N Engl J Med
  • PLoS One
    • RHEDIN S , Hamrin J, Naucler P, Bennet R, et al
      • Correction: Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden.
    • MOWLS DS , Cheruvu VK, Zullo MD
      • Correction: Influenza Vaccination in Adults with Chronic Obstructive Pulmonary Disease: The Impact of a Diagnostic Breathing Test on Vaccination Rates.
    • MELEN K , Partinen M, Tynell J, Sillanpaa M, et al
      • No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland.
    • WANG D , Zhang T, Wu J, Jiang Y, et al
      • Socio-Economic Burden of Influenza among Children Younger than 5 Years in the Outpatient Setting in Suzhou, China.
    • FALKEBORN T , Brave A, Larsson M, Akerlind B, et al
      • Endocine, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination.
    • GILLMAN A , Muradrasoli S, Soderstrom H, Nordh J, et al
      • Resistance Mutation R292K Is Induced in Influenza A(H6N2) Virus by Exposure of Infected Mallards to Low Levels of Oseltamivir.
    • MOSS AJ , Gaughran FP, Karasu A, Gilbert AS, et al
      • Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination.
    • CORZO CA , Culhane M, Dee S, Morrison RB, et al
      • Airborne detection and quantification of Swine influenza a virus in air samples collected inside, outside and downwind from Swine barns.
    • SCHLAUDECKER EP , Steinhoff MC, Omer SB, McNeal MM, et al
      • IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization.
    • NEUHAUS V , Schwarz K, Klee A, Seehase S, et al
      • Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique.
    • DARWISH I , Banner D, Mubareka S, Kim H, et al
      • Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza.
    • LIAO Q , Bai T, Zhou L, Vong S, et al
      • Seroprevalence of Antibodies to Highly Pathogenic Avian Influenza A (H5N1) Virus among Close Contacts Exposed to H5N1 Cases, China, 2005-2008.
    • STAB V , Nitsche S, Niezold T, Storcksdieck Genannt Bonsmann M, et al
      • Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus.
  • Virus Res
    • IMAI M , Herfst S, Sorrell EM, Schrauwen EJ, et al
-
------
 
Research Articles Abstracts?August 30 2013 Issue

Research Articles Abstracts?August 30 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts?August 30 2013 Issue

____

This week?s abstracts:
__
  1. Ohgitani E, Kita M, Mazda O, Imanishi J, et al.
    • Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.
  2. Mertz D, Kim TH, Johnstone J, Lam PP, et al.
    • Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.
  3. Kmietowicz Z.
    • New expert group agrees plan to analyse full data on oseltamivir.
  4. Liedmann S, Hrincius ER, Anhlan D, McCullers JA, et al.
    • New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variant.
  5. Marty FM, Man CY, van der Horst C, Francois B, et al.
    • Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study.
  6. Brand PL.
  7. Blanken MO, Rovers MM, Bont L.
  8. Gomila RC, Suphaphiphat P, Judge C, Spencer T, et al.
    • Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments.
-
-------
 
Research Articles Abstracts?September 6 2013 Issue

Research Articles Abstracts?September 6 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?September 6 2013 Issue

____

This week?s abstracts:
  • Arch Virol
    • MCINTYRE CL , Savolainen-Kopra C, Hovi T, Simmonds P, et al
    • QIN X , Zhang C, Zhao Y, Zhao X, et al
      • Genetic variability of subgroup A and B respiratory syncytial virus strains circulating in southwestern China from 2009 to 2011.
    • COSTA C , Curtoni A, Sidoti F, Balloco C, et al
      • Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients.
  • BMJ
  • Cell
    • THARAKARAMAN K , Raman R, Viswanathan K, Stebbins NW, et al
      • Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity.
  • Epidemiol Infect
    • ADEGBOYE OA , Kotze D
      • Epidemiological analysis of spatially misaligned data: a case of highly pathogenic avian influenza virus outbreak in Nigeria.
  • J Clin Microbiol
    • ZHANG J , Feng Y, Hu D, Lv H, et al
      • Rapid and sensitive detection of H7N9 avian influenza virus using reverse transcription loop-mediated isothermal amplification.
  • J Gen Virol
    • YANG G , Li S, Blackmon S, Ye J, et al
      • Mutation tryptophan to leucine at the position 222 of hemagglutinin could facilitate H3N2 influenza A virus infection in dogs.
  • J Infect
    • YANG P , Wang Q, Pang X, Chen L, et al
      • The first patient infected with avian influenza A (H7N9) virus appearing in summer, China.
  • J Infect Dis
    • CHI Y , Zhu Y, Wen T, Cui L, et al
      • Cytokine and Chemokine Levels in Patients Infected with the Novel Avian Influenza A (H7N9) Virus in China.
    • XU L , Bao L, Deng W, Dong L, et al
      • The Novel Avian-Origin Human A (H7N9) Influenza Virus Could be Transmitted between Ferrets via Respiratory Droplets.
    • DAWOOD FS , Chaves SS, Perez A, Reingold A, et al
      • Complications and associated bacterial co-infections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.
  • J Virol
    • HUA L , Yao S, Pham D, Jiang L, et al
      • Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection.
  • J Virol Methods
    • LEE JS , Chowdhury MY, Moon HJ, Choi YK, et al
      • The Highly Conserved HA2 Protein of the Influenza A Virus Induces a Cross Protective Immune Response.
    • LI Y , Wu T, Qi X, Ge Y, et al
      • Simultaneous detection of hemagglutinin and neuraminidase genes of novel influenza A (H7N9) by duplex real-time reverse transcription polymerase chain reaction.
    • KOBAYASHI T , Hirose J, Wu H, Sano K, et al
      • Application of electrolysis for inactivation of an antiviral drug that is one of possible selection pressure to drug-resistant influenza viruses.
    • MITAMURA K , Shimizu H, Yamazaki M, Ichikawa M, et al
      • Clinical evaluation of highly sensitive silver amplification immunochromatography systems for rapid diagnosis of influenza.
  • Pediatrics
  • PLoS One
    • GELLER R , Andino R, Frydman J
      • Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus.
    • KJOS SA , Irving SA, Meece JK, Belongia EA, et al
      • Elementary school-based influenza vaccination: evaluating impact on respiratory illness absenteeism and laboratory-confirmed influenza.
    • WEAVER EA , Barry MA
    • YUNG CF , Andrews N, Hoschler K, Miller E, et al
      • Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England.
  • Proc Natl Acad Sci U S A
    • WONG SM , Bernui M, Shen H, Akerley BJ, et al
      • Genome-wide fitness profiling reveals adaptations required by Haemophilus in coinfection with influenza A virus in the murine lung.
  • Vaccine
    • CHA RM , Smith D, Shepherd E, Davis CT, et al
      • Suboptimal protection against highly pathogenic avian influenza (H5N1) viruses from Vietnam in ducks vaccinated with commercial poultry vaccines.
    • RUDENKO L , Isakova-Sivak I, Donina S
      • H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.
-
-------
 
Research Articles Abstracts?September 13 2013 Issue

Research Articles Abstracts?September 13 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts?September 13 2013 Issue
__

This week?s abstracts:
  • Ann Intern Med
  • Antiviral Res
    • BURNHAM AJ , Baranovich T, Govorkova EA
      • Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.
    • NASSER ZH , Swaminathan K, Muller P, Downard KM, et al
      • Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry.
    • GARCIA-CRESPO KE , Chan CC, Gabryszewski SJ, Percopo CM, et al
      • Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.
  • Arch Virol
    • TAMAKI S , Bui VN, Ngo LH, Ogawa H, et al
      • Virucidal effect of acidic electrolyzed water and neutral electrolyzed water on avian influenza viruses.
  • Biochem Biophys Res Commun
    • PARK S , Kim JI, Lee I, Lee S, et al
      • Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses.
  • Biochemistry
    • SASSAKI GL , Elli S, Rudd TR, Macchi E, et al
      • Human (alpha2-->6) and avian (alpha2-->3) sialylated receptors of influenza A virus show distinct conformations and dynamics in solution.
  • Drug Saf
    • ANKRAH DN , Mantel-Teeuwisse AK, De Bruin ML, Amoo PK, et al
      • Incidence of adverse events among healthcare workers following H1N1 Mass immunization in Ghana: a prospective study.
  • Drugs
    • MCKEAGE K
      • Inactivated Quadrivalent Split-Virus Seasonal Influenza Vaccine (Fluarix Quadrivalent): A Review of Its Use in the Prevention of Disease Caused by Influenza A and B.
  • Epidemiol Infect
    • PECI A , Marchand-Austin A, Winter AL, Gubbay JB, et al
      • Optimal number of samples to test for institutional respiratory infection outbreaks in Ontario.
  • J Virol
    • JONES JC , Baranovich T, Zaraket H, Guan Y, et al
    • ZHIRNOV OP , Klenk HD
      • Influenza A virus proteins NS1 and HA along with M2 are involved in stimulation of autophagy in infected cells.
    • HONG M , Lee PS, Hoffman RM, Zhu X, et al
    • TAN Y , Guan W, Tsan-Yuk Lam T, Pan S, et al
      • Differing epidemiological dynamics of influenza B lineages in Guangzhou, southern China, 2009-2010.
    • ZHANG S , Chen L, Zhang G, Yan Q, et al
      • An Amino Acid of Human Parainfluenza Virus Type 3 Nucleoprotein Is Critical for Template Function and Cytoplasmic Inclusion Body Formation.
    • YANG H , Carney PJ, Chang JC, Villanueva JM, et al
    • HOOPER KA , Bloom JD
    • PRABHU N , Ho AW, Wong KH, Hutchinson PE, et al
      • Interferon-gamma regulates contraction of the influenza-specific CD8 T cell response and limits the size of the memory population.
  • MMWR Morb Mortal Wkly Rep
    • ?
      • Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions - United States, 2011-12 influenza season.
  • N Engl J Med
  • PLoS One
    • ASHBAUGH AR , Herbert CF, Saimon E, Azoulay N, et al
      • The Decision to Vaccinate or Not during the H1N1 Pandemic: Selecting the Lesser of Two Evils?
    • HAN N , Mu Y
      • Locking the 150-cavity open: in silico design and verification of influenza neuraminidase inhibitors.
    • HOFFMANN M , Muller MA, Drexler JF, Glende J, et al
      • Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.
    • PRIORE SF , Kierzek E, Kierzek R, Baman JR, et al
    • STEGLICH C , Grund C, Ramp K, Breithaupt A, et al
      • Chimeric Newcastle Disease Virus Protects Chickens against Avian Influenza in the Presence of Maternally Derived NDV Immunity.
    • HSU KC , Hung HC, Horng JT, Fang MY, et al
      • Parallel screening of wild-type and drug-resistant targets for anti-resistance neuraminidase inhibitors.
  • Vaccine
    • BRETELER JK , Tam JS, Jit M, Ket JC, et al
      • Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: A systematic review and meta-analysis.
    • YUET SHEUNG CAROL Y , Yee Tak Daniel F, Lai Yin Irene L, Chu S, et al
      • Prevalence and predictors of maternal seasonal influenza vaccination in Hong Kong.
    • JACOBY P
      • Is it necessary to adjust for calendar time in a test negative design?: Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8.
    • PEPIN S , Donazzolo Y, Jambrecina A, Salamand C, et al
      • Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.
    • CHAMBERS CD , Johnson D, Xu R, Luo Y, et al
      • Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
    • WICKER S , Rabenau HF, von Gierke L, Francois G, et al
      • Hepatitis B and influenza vaccines: Important occupational vaccines differently perceived among medical students.
    • CABAN-MARTINEZ AJ , Arlinghaus A, Reme SE
      • Correlates of seasonal flu vaccination among U.S. home health aides.
    • SHAW CA , Galarneau JR, Bowenkamp KE, Swanson KA, et al
      • The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease.
    • LOUIK C , Ahrens K, Kerr S, Pyo J, et al
      • Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: Exposure prevalence, preterm delivery, and specific birth defects.
    • ESPOSITO S , Salvini F, Menni F, Scala A, et al
      • Preliminary data on immunogenicity, safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation.
    • KUNZE U , Bohm G, Groman E
      • Influenza vaccination in Austria from 1982 to 2011: A country resistant to influenza prevention and control.
  • Virus Res
    • KAPLAN BS , Webby RJ
      • The Avian and Mammalian Host Range of Highly Pathogenic Avian H5N1 Influenza.
-
--------
 
Research Articles Abstracts?September 20 2013 Issue

Research Articles Abstracts?September 20 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts?September 20 2013 Issue


This week?s abstracts:
  • J Infect Dis
    • VAN DER VELDEN MV , Fritz R, Pollabauer EM, Portsmouth D, et al
      • Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in a Pediatric Population.
  • J Virol Methods
    • DONG J , Harada M, Yoshida S, Kato Y, et al
      • Expression and purification of bioactive hemagglutinin protein of highly pathogenic avian influenza A (H5N1) in silkworm larvae.
  • PLoS One
    • NASREEN S , Uddin Khan S, Azziz-Baumgartner E, Hancock K, et al
      • Seroprevalence of Antibodies against Highly Pathogenic Avian Influenza A (H5N1) Virus among Poultry Workers in Bangladesh, 2009.
    • DEBIN M , Turbelin C, Blanchon T, Bonmarin I, et al
      • Evaluating the feasibility and participants' representativeness of an online nationwide surveillance system for influenza in france.
    • ZHOU L , Su Q, Xu Z, Feng A, et al
      • Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in china by season (2009/10 to 2011/12).
    • SUGISAKI K , Seki N, Tanabe N, Saito R, et al
      • Effective school actions for mitigating seasonal influenza outbreaks in niigata, Japan.
    • FRENSING T , Heldt FS, Pflugmacher A, Behrendt I, et al
      • Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.
  • Proc Natl Acad Sci U S A
    • ESSERE B , Yver M, Gavazzi C, Terrier O, et al
      • Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses.
  • Vaccine
    • CHU CS , Boyer JD, Jawad A, McDonald K, et al
      • Immunologic consequences of chemotherapy for ovarian cancer: Impaired responses to the influenza vaccine.
  • Virus Res
    • XIONG X , Tuzikov A, Coombs P, Martin S, et al
      • Recognition of Sulphated and Fucosylated Receptor Sialosides by A/Vietnam/1194/2004 (H5N1) Influenza Virus.
-
-------
 
Research Articles Abstracts ? September 27 2013 Issue

Research Articles Abstracts ? September 27 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts ? September 27 2013 Issue

__

This week?s abstracts:
  • Antiviral Res
    • PAN P , Li L, Li Y, Li D, et al
      • Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
    • WOO HM , Kim KS, Lee JM, Shim HS, et al
      • Single-stranded DNA aptamer that specifically binds to the influenza virus NS1 protein suppresses interferon antagonism.
  • Arch Virol
    • CHEN J , Yan B, Chen Q, Yao Y, et al
      • Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
  • BMJ
  • J Clin Microbiol
    • SU S , Chen J, Cao Z, Lai A, et al
      • Detection of antibodies against avian influenza virus subtypes H7 and H9 among veterinarians in Guangdong province, China.
    • SALEZ N , de Lamballerie X, Zandotti C, Gazin C, et al
      • Improved sensitivity of the novel Xpert(R) Flu test for detection of influenza B virus.
    • DENISON AM , Deleon-Carnes M, Blau DM, Shattuck EC, et al
      • Molecular Characterization of Staphylococcus aureus and Influenza Virus Coinfections in Patients with Fatal Pneumonia.
  • J Gen Virol
    • MCINTYRE CL , Knowles NJ, Simmonds P
      • Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types.
  • J Virol
    • ZHU X , Guo YH, Jiang T, Wang YD, et al
      • A Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by a Murine Antibody against the A/goose/Guangdong/1/96 Hemagglutinin.
    • XIAO H , Killip MJ, Staeheli P, Randall RE, et al
      • The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm.
    • KRAFT AR , Wlodarczyk MF, Kenney LL, Selin LK, et al
      • PC61 (anti-CD25) treatment inhibits influenza-A expanded Tregs and severe lung pathology during a subsequent heterologous LCMV infection.
    • SUGITA Y , Sagara H, Noda T, Kawaoka Y, et al
    • SMITH SE , Gibson MS, Wash RS, Ferrara F, et al
    • MCNALLY B , Ye F, Willette M, Flano E, et al
      • Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection.
  • J Virol Methods
    • SHCHERBIK S , Sergent SB, Davis WG, Shu B, et al
      • Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.
  • MMWR Morb Mortal Wkly Rep
    • ?
      • Influenza vaccination coverage among health-care personnel - United States, 2012-13 influenza season.
    • ?
      • Influenza vaccination coverage among pregnant women - United States, 2012-13 influenza season.
  • PLoS One
    • CHEN X , Yang Z, Lu Y, Xu Q, et al
      • Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study.
    • SEVILLA-REYES EE , Chavaro-Perez DA, Piten-Isidro E, Gutierrez-Gonzalez LH, et al
      • Correction: Protein Clustering and RNA Phylogenetic Reconstruction of the Influenza a Virus NS1 Protein Allow an Update in Classification and Identification of Motif Conservation.
    • WU Z , Hao R, Li P, Zhang X, et al
      • MicroRNA Expression Profile of Mouse Lung Infected with 2009 Pandemic H1N1 Influenza Virus.
    • ANGIONE SL , Inde Z, Beck CM, Artenstein AW, et al
      • Microdroplet sandwich real-time rt-PCR for detection of pandemic and seasonal influenza subtypes.
    • LUGOVTSEV VY , Melnyk D, Weir JP
      • Heterogeneity of the MDCK Cell Line and Its Applicability for Influenza Virus Research.
    • ALI A , Khowaja AR, Bashir MZ, Aziz F, et al
      • Role of Human Metapneumovirus, Influenza A Virus and Respiratory Syncytial Virus in Causing WHO-Defined Severe Pneumonia in Children in a Developing Country.
    • HILLER KM , Stoneking L, Min A, Rhodes SM, et al
      • Syndromic surveillance for influenza in the emergency department-a systematic review.
    • SAITO MM , Imoto S, Yamaguchi R, Tsubokura M, et al
      • Enhancement of Collective Immunity in Tokyo Metropolitan Area by Selective Vaccination against an Emerging Influenza Pandemic.
    • EL MOUSSI A , Pozo F, Ben Hadj Kacem MA, Ledesma J, et al
      • Virological Surveillance of Influenza Viruses during the 2008-09, 2009-10 and 2010-11 Seasons in Tunisia.
    • BLANKEN MO , Koffijberg H, Nibbelke EE, Rovers MM, et al
      • Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.
  • Proc Natl Acad Sci U S A
    • GAVAZZI C , Yver M, Isel C, Smyth RP, et al
      • A functional sequence-specific interaction between influenza A virus genomic RNA segments.
  • Vaccine
    • KACZMAREK MC , Duong UT, Ware RS, Lambert SB, et al
      • The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged >/=6 months to <36 months: A comparison of published and unpublished studies.
    • LIU G , Zhang F, Shi J, Tian G, et al
      • A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge.
    • PEASAH SK , Azziz-Baumgartner E, Breese J, Meltzer MI, et al
      • Influenza cost and cost-effectiveness studies globally - A review.
    • GORSE GJ , Falsey AR, Johnson CM, Morrison D, et al
      • Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.
    • EFFLER PV , Kelly H
      • Statement that clinical studies had demonstrated bioCSL's seasonal influenza vaccines had acceptable safety profile in all age groups is not supported by the data.
  • Virus Res
    • LEE YH , Lai CL, Hsieh SH, Shieh CC, et al
      • Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model.
    • VEMULA SV , Amen OA, Katz JM, Donis R, et al
      • Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.
    • LEE YN , Park CK, Kim SH, Lee DS, et al
      • Characterization in vitro and in vivo of a novel porcine parainfluenza virus 5 isolate in Korea.
    • SHEN H , Xue C, Lv L, Wang W, et al
      • Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease.
    • LONDT BZ , Brookes SM, Nash BJ, Nunez A, et al
      • Enhanced infectivity of H5N1 highly pathogenic avian influenza (HPAI) virus in pig ex vivo respiratory tract organ cultures following adaptation by in vitro passage.
-
-------
 
Research Articles Abstracts ? October 5 2013 Issue

Research Articles Abstracts ? October 5 2013 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts ? October 5 2013 Issue


This week?s abstracts:
__

  • Antimicrob Agents Chemother
    • TAMURA D , Nguyen HT, Sleeman K, Levine M, et al
      • Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment.
  • Antiviral Res
    • DOYLE TM , Hashem AM, Li C, Domselaar GV, et al
      • Universal Anti-Neuraminidase Antibody Inhibiting all Influenza A Subtypes.
    • JONES BG , Hayden RT, Hurwitz JL
      • Inhibition of Primary Clinical Isolates of Human Parainfluenza Virus by DAS181 in Cell Culture and in a Cotton Rat Model.
  • Arch Virol
    • KHAN SU , Berman L, Haider N, Gerloff N, et al
      • Investigating a crow die-off in January-February 2011 during the introduction of a new clade of highly pathogenic avian influenza virus H5N1 into Bangladesh.
  • BMJ
  • Epidemiol Infect
    • GEFENAITE G , Tacken M, Kolthof J, Mulder B, et al
      • Predictors of influenza in the adult population during seasonal and A(H1N1)pdm09 pandemic influenza periods.
  • J Clin Microbiol
    • ROUSSY JF , Abed Y, Bouhy X, Boivin G, et al
      • Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly receiving a suboptimal dose of antiviral prophylaxis.
    • SUN Y , Jia T, Sun Y, Han Y, et al
      • External Quality Assessment for Avian Influenza A (H7N9) Virus Detection Using Armored RNA.
  • J Gen Virol
    • XU L , Bao L, Yuan J, Li F, et al
  • J Immunol
    • ROBINSON KM , Choi SM, McHugh KJ, Mandalapu S, et al
      • Influenza A Exacerbates Staphylococcus aureus Pneumonia by Attenuating IL-1beta Production in Mice.
  • J Infect Dis
    • ROBINSON KM , McHugh KJ, Mandalapu S, Clay ME, et al
      • Influenza A Virus Exacerbates Staphylococcus aureus Pneumonia in Mice by Attenuating Antimicrobial Peptide Production.
  • J Virol
    • TRAN V , Moser LA, Poole DS, Mehle A, et al
      • Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread.
    • SELADI-SCHULMAN J , Steel J, Lowen AC
      • Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo.
    • BOSE S , Heath CM, Shah PA, Alayyoubi M, et al
      • Mutations in the parainfluenza virus 5 fusion (F) protein reveal domains important for fusion triggering and metastability.
    • HOUSER KV , Pearce MB, Katz JM, Tumpey TM, et al
      • Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
  • JAMA
    • CAPLAN A , Shah NR
      • Managing the Human Toll Caused by Seasonal Influenza: New York State's Mandate to Vaccinate or Mask.
  • PLoS One
    • ASKOVICH PS , Sanders CJ, Rosenberger CM, Diercks AH, et al
      • Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses.
    • SASAKI Y , Hagiwara K, Kakisaka M, Yamada K, et al
      • Correction: Importin alpha3/Qip1 Is Involved in Multiplication of Mutant Influenza Virus with Alanine Mutation at Amino Acid 9 Independently of Nuclear Transport Function.
    • PETRIE JG , Ohmit SE, Cowling BJ, Johnson E, et al
    • PHAM VL , Nakayama M, Itoh Y, Ishigaki H, et al
      • Pathogenicity of Pandemic H1N1 Influenza A Virus in Immunocompromised Cynomolgus Macaques.
    • FONVILLE JM , Burke DF, Lewis NS, Katzelnick LC, et al
      • Quantifying the Fitness Advantage of Polymerase Substitutions in Influenza A/H7N9 Viruses during Adaptation to Humans.
    • BUGGELE WA , Krause KE, Horvath CM
      • Small RNA Profiling of Influenza A Virus-Infected Cells Identifies miR-449b as a Regulator of Histone Deacetylase 1 and Interferon Beta.
    • LE VL , Courtney CL, Steel J, Compans RW, et al
      • Closely Related Influenza Viruses Induce Contrasting Respiratory Tract Immunopathology.
    • KIM SH , Kim JY, Choi Y, Nguyen HH, et al
      • Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection.
    • BALASUBRAMANIAM VR , Hong Wai T, Ario Tejo B, Omar AR, et al
      • Highly Pathogenic Avian Influenza Virus Nucleoprotein Interacts with TREX Complex Adaptor Protein Aly/REF.
  • Vaccine
    • TREANOR JJ , Essink B, Hull S, Reed S, et al
      • Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.
    • MAHER L , Hope K, Torvaldsen S, Lawrence G, et al
      • Influenza vaccination during pregnancy: Coverage rates and influencing factors in two urban districts in Sydney.
  • Virology
    • LAKDAWALA SS , Shih AR, Jayaraman A, Lamirande EW, et al
      • Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets.
    • YE J , Xu Y, Harris J, Sun H, et al
      • Mutation from arginine to lysine at the position 189 of hemagglutinin contributes to the antigenic drift in H3N2 swine influenza viruses.
    • ALSUWAIDI AR , Almarzooqi S, Albawardi A, Benedict S, et al
      • Cellular bioenergetics, caspase activity and glutathione in murine lungs infected with influenza A virus.
    • NI F , Kondrashkina E, Wang Q
    • ZU R , Dong L, Qi X, Wang D, et al
      • Virological and serological study of human infection with swine influenza A H1N1 virus in China.
    • GLINEUR SF , Renshaw RW, Percopo CM, Dyer KD, et al
  • Virus Res
    • YAMAMOTO N , Sakoda Y, Okamatsu M, Kida H, et al
      • Polymerase complex with lysine at position 627 of the PB2 of influenza virus A/Hong Kong/483/97 (H5N1) efficiently transcribes and replicates virus genes in mouse cells.
-
-------
 
You must log in or register to reply here.
Back
Top